🇺🇸 FDA
Patent

US 7179899

Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72

granted A61KA61K2039/505

Quick answer

US patent 7179899 (Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505